Title : Acute toxicity analysis of an inhibitor of BCL2, Disarib, in rats.

Pub. Date : 2021 May 11

PMID : 33976278






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Notably, a head-to-head comparison of Disarib to ABT199, the only FDA approved BCL2 inhibitor revealed that Disarib is as potent as ABT199. venetoclax B cell leukemia/lymphoma 2 Mus musculus